AYTU (aytubio.com) Earnings per share growth this year

Official company branding of Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma, Inc. (AYTU) is developing pediatric ADHD therapy, optimizing supply chains through partnerships with pharmacy chains. The annual earnings per share change chart illustrates the dynamics of this process, where the value 45.40 captures this metric. The company is implementing eco-friendly waste disposal, while stable demand for pediatric medications and expanded insurance coverage support the growth of its customer base.

AYTU (Aytu BioPharma) Earnings per share growth in current year history from 07/04/2022 to 11/16/2026

Financial and market metric breakdowns for Aytu BioPharma (AYTU)

- stock value and consensus price forecast:
Basic company analysis:aytubio.com (AYTU)
Manufactured products of aytubio.com

Aytu BioPharma, Inc. (AYTU) provides the market with high-quality pediatric drugs, leveraging the trust of physicians. The annual net income per share trend reflects the efficiency of this business model through the percentage change in EPS. This indicator measures earnings growth rates, smoothing market volatility into a single trend. The ascending line confirms the undervaluation of assets, despite risks associated with a shift in the industry cycle. Stable profit growth underscores the fundamental resilience of the business.

Main competitors

Earnings per share growth rate in current year Vertex Pharmaceuticals Inc. (VRTX)|ALNY (Alnylam) - Earnings growth in current year|Earnings per share growth this year INSM (Insmed)|Net earnings per share growth this year UTHR (United Therapeutics Corporation)|BMRN (BioMarin Pharmaceutical Inc.) - Earnings per share increase in current year|Earnings per share growth in current year BridgeBio BBIO|Earnings per share increase in current year BGM|Cogent Biosciences - Earnings growth in current year|Earnings per share increase in current year XERS (Xeris Biopharma)|KROS: Earnings growth in current year|Arcturus Therapeutics Inc (ARCT) - Earnings growth in current year|Earnings per share growth in current year Eton Pharma|KMDA: Earnings per share increase in current year|Earnings per share growth in current year fulcrumtx.com (FULC)|Net earnings per share growth this year Abeona Therapeutics Inc. ABEO|Earnings growth in current year MREO (Mereo BioPharma Group)|PLX (Protalix BioTherapeutics Inc.) - Earnings per share trend in current year|PLRX - Earnings per share growth in current year|APLT - Earnings growth in current year|RNTX: Earnings growth in current year|Earnings per share growth rate in current year Gelteq Limited Inc (GELS)|CMMB (Chemomab Therapeutics Ltd) - Earnings growth in current year|Earnings per share growth this year SRXH (SRx Health Solutions)|Net earnings per share growth this year PLRZ (Polyrizon Ltd)|AEZS - Earnings per share growth rate in current year|Earnings per share growth in current year Cyclo Therapeutics Inc. CYTH|Inozyme Pharma, Inc. (INZY) - Earnings per share growth rate in current year|RPHM: Net earnings per share growth this year|Earnings per share growth rate in current year COSCIENS Biopharma Inc